Fundz

BioCryst Pharmaceuticals Appoints Babar Ghias as Chief Financial Officer

PUBLIC · BCRXJul 07, 2025

Position

Chief Financial Officer

Company

BioCryst Pharmaceuticals

Babar Ghias
bghias@biocryst.com
DurhamBiotechnologyHealth CareTherapeutics

Description

BioCryst Pharmaceuticals announced the appointment of Babar Ghias as the new Chief Financial Officer (CFO) and head of corporate development. Ghias brings extensive experience in financial leadership and operational expertise to the company.

Quick answer

BioCryst Pharmaceuticals Appoints Babar Ghias as Chief Financial Officer (July 7, 2025). BioCryst Pharmaceuticals is based in Durham, North Carolina, United States.

Who is the new Chief Financial Officer at BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals named Babar Ghias Chief Financial Officer, announced July 7, 2025.
What did BioCryst Pharmaceuticals announce on July 7, 2025?
BioCryst Pharmaceuticals announced the appointment of Babar Ghias as the new Chief Financial Officer (CFO) and head of corporate development. Ghias brings extensive experience in financial leadership and operational expertise to the company.
What does BioCryst Pharmaceuticals do?
BioCryst is focused on developing novel therapies for diseases with significant unmet needs.
Where is BioCryst Pharmaceuticals based?
BioCryst Pharmaceuticals is based in Durham, North Carolina, United States.
Which similar companies made leadership changes around the same time?
Tivic (July 8, 2025), Centaurus Therapeutics (July 8, 2025), Jazz Pharmaceuticals plc (July 10, 2025) and BrainXell (July 10, 2025) also announced leadership changes within 45 days of BioCryst Pharmaceuticals.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at BioCryst Pharmaceuticals, and when

A new leader at BioCryst Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day BioCryst Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BioCryst Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BioCryst Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BioCryst Pharmaceuticals

Location

4505 Emperor Boulevard

Durham, North Carolina, United States

About

BioCryst is focused on developing novel therapies for diseases with significant unmet needs. The company has already commercialized ORLADEYO® (berotralstat), a once-daily oral plasma kallikrein inhibitor, and continues to develop a pipeline of small-molecule and protein therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BioCryst Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Babar
Likely contact at this company
••••••••@••••••••

See Babar's verified email →

Carlos
Likely contact at this company
••••••••@••••••••

See Carlos's verified email →

Griffin
Likely contact at this company
••••••••@••••••••

See Griffin's verified email →

Mike
Likely contact at this company
••••••••@••••••••

See Mike's verified email →

Suzie
Likely contact at this company
••••••••@••••••••

See Suzie's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for BioCryst Pharmaceuticals's next move

Learn about Strategic plan

BioCryst Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.